Fagan Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-20,440
| Closed | -$2.27M | – | 121 |
|
2019
Q4 | $2.27M | Buy |
20,440
+165
| +0.8% | +$18.3K | 0.74% | 41 |
|
2019
Q3 | $2.01M | Buy |
20,275
+550
| +3% | +$54.6K | 0.78% | 40 |
|
2019
Q2 | $1.96M | Buy |
19,725
+355
| +2% | +$35.2K | 0.8% | 35 |
|
2019
Q1 | $2.14M | Buy |
19,370
+1,245
| +7% | +$137K | 0.91% | 33 |
|
2018
Q4 | $1.67M | Buy |
18,125
+515
| +3% | +$47.4K | 0.86% | 38 |
|
2018
Q3 | $1.94M | Buy |
17,610
+1,370
| +8% | +$151K | 0.8% | 40 |
|
2018
Q2 | $1.52M | Buy |
16,240
+195
| +1% | +$18.2K | 0.68% | 47 |
|
2018
Q1 | $1.33K | Buy |
16,045
+1,995
| +14% | +$165 | 0.57% | 52 |
|
2017
Q4 | $1.28K | Buy |
+14,050
| New | +$1.28K | 0.52% | 55 |
|